Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Cash Flows from Operating Activities:
Net (Loss) Income	$ (18,305,438)	$ 3,371,415
Adjustments to reconcile net income (loss) to cash provided by (used in) operating activities:
Amortization of right of use assets	5,670,233	5,493,263
Depreciation, amortization, and accretion	24,989,186	22,398,171
Income taxes	(136,669)	(290,427)
(Gain) loss on disposition of assets	(35,839)	720,691
Bad debt expense	385,091	318,520
Equity in (income) loss of unconsolidated affiliates	(6,544,671)	17,283,281
Amortization of bond premium	(1,262,729)	(1,302,048)
Other investment loss (income)	19,874,269	(29,059,717)
Compensation paid in stock	1,061,755	917,795
Other	60,000	0
Changes in operating assets and liabilities:
Accounts receivable	431,438	(610,863)
Interest receivable	27,165	101,869
Prepaid expenses	(1,008,648)	162,245
Deferred policy acquisition costs	(782,855)	(389,266)
Other assets	(281)	(52,659)
Other liabilities, exclusive of debt	(74,724)	(83,785)
Accounts payable, accrued expenses, unpaid losses and loss adjustments, and other	(1,810,360)	3,917,430
Lease liabilities	(5,403,979)	(5,356,529)
Unearned premiums	590,543	3,286,324
Deferred revenue	134,003	415,870
Net Cash Provided by Operating Activities	17,857,490	21,241,580
Cash Flows from Investing Activities:
Payments on short-term payables for business acquisitions	(14,513)	(496,899)
Investment in unconsolidated affiliates	0	(21,000)
Capital expenditures	(27,898,145)	(32,201,191)
Proceeds from sales of investments	287,784,497	355,082,233
Purchase of investments	(273,418,446)	(294,263,327)
Net Cash (Used in) Provided by Investing Activities	(13,546,607)	28,099,816
Cash Flows from Financing Activities:
Proceeds from issuance of stock	525,256	0
Proceeds from borrowings	11,500,000	13,500,000
Stock repurchased	(5,752,737)	(18,350,693)
Contributions from noncontrolling interests	378,290	206,082
Distributions to noncontrolling interests	(7,084,357)	(37,512,061)
Repayments on borrowings	(2,293,195)	(1,272,962)
Collateral receipt (release), net	3,936,347	(4,127,540)
Offering costs	(3,286)	0
Net Cash Provided by (Used in) Financing Activities	1,206,318	(47,557,174)
Net (Decrease) Increase in Cash, Cash Equivalents, and Restricted Cash	5,517,201	1,784,222
Cash, Cash Equivalents, and Restricted Cash, Beginning of Year	41,197,426	39,413,204
Cash, Cash Equivalents, and Restricted Cash, End of Year	46,714,627	41,197,426
Interest Paid in Cash	2,346,423	1,527,915
Supplemental Schedules of Non-cash Investing and Financing Activities
Distribution receivable from real estate fund	4,405,100	0
Stock issued as consideration for redeemable noncontrolling interest	0	13,399,161
Investment transferred as compensation for stock repurchased	$ 0	$ 1,474,292